IP Library Assignment 066356/0108
Patent Assignment
Reel/Frame 066356/0108

Change of Name

Recorded: 2024-01-19 Pages: 7
Assignor
CELLULAR BIOMEDICINE GROUP, INC.
Executed: 2023-11-15
Assignee
ABELZETA INC.
9605 MEDICAL CENTER DRIVE, SUITE 100, ROCKVILLE, MARYLAND, 20850
Covered Properties (17)
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof
Application: 17/721,647 →
Publication: US 2022/0249568
Combined Chimeric Antigen Receptor Targeting CD19 and CD20 and Application Thereof
Application: 17/911,502 →
Publication: US 2023/0104705
Combined Chimeric Antigen Receptor Targeting CD19 and CD20 and Applications Thereof
Application: 17/911,524 →
Publication: US 2023/0212255
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof
Application: 18/183,681 →
Publication: US 2024/0139243
Construction of Chimeric Antigen Receptor Targeting CD20 Antigen and Activity Identification of Engineered T Cells Thereof
Application: 17/831,637 →
Publication: US 2022/0340640
Construction of Chimeric Antigen Receptor Targeting CD20 Antigen and Activity Identification of Engineered T Cells Thereof
Application: 18/173,187 →
Publication: US 2023/0242613
Chimeric Antigen Receptors Targeting CD20
Application: 18/263,050 →
Publication: US 2024/0115605
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof
Application: 63/154,032 →
Construction of Chimeric Antigen Receptor Targeting CD20 Antigen and Activity Identification of Engineered T Cells Thereof
Application: 63/142,216 →
Construction of Chimeric Antigen Receptor Targeting CD20 Antigen and Activity Identification of Engineered T Cells Thereof
Application: 63/154,040 →
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof
Application: 16/877,069 →
Publication: US 2021/0290673
Combined Chimeric Antigen Receptor Targeting CD19 and CD20 and Application Thereof
Application: 17/475,766 →
Publication: US 2022/0031752
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof
Application: 17/750,658 →
Publication: US 2022/0288123
Construction of Chimeric Antigen Receptor Targeting CD20 Antigen and Activity Identification of Engineered T Cells Thereof
Application: 16/484,482 →
Publication: US 2020/0002400
Construction of Chimeric Antigen Receptor Targeting CD20 Antigen and Activity Identification of Engineered T Cells Thereof
Application: 17/352,915 →
Publication: US 2021/0361710
Construction of Chimeric Antigen Receptor Targeting CD20 Antigen and Activity Identification of Engineered T Cells Thereof
Application: 17/723,859 →
Publication: US 2022/0324940
Construction of Chimeric Antigen Receptor Targeting CD20 Antigen and Activity Identification of Engineered T Cells Thereof
Application: 17/750,855 →
Publication: US 2022/0281945
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 1, 2019
From: YAO, YIHONG; HUANG, JIAQI; ZHU, SHIGUI; ZHU, WEI
To: CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.; CELLULAR BIOMEDICINE GROUP (WUXI) LTD.
Reel/Frame 050889/0445 →
Assignment of Assignor's Interest May 27, 2020
From: YAO, YIHONG; LI, YANFENG; WEI, YUTIAN; ZHU, SHIGUI
To: SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.; WUXI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
Reel/Frame 052761/0406 →
Assignment of Assignor's Interest Mar 3, 2021
From: YAO, YIHONG; HUANG, JIAQI; YAO, XIN
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 055481/0253 →
Assignment of Assignor's Interest Mar 3, 2021
From: YAO, YIHONG; HUANG, JIAQI; YAO, XIN
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 055481/0160 →
Assignment of Assignor's Interest Mar 29, 2021
From: YAO, YIHONG; HUANG, JIAQI; YAO, XIN
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 055754/0001 →
Assignment of Assignor's Interest Jun 3, 2021
From: CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 056426/0472 →
Assignment of Assignor's Interest Jun 3, 2021
From: CELLULAR BIOMEDICINE GROUP (WUXI) LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 056426/0577 →
Assignment of Assignor's Interest Jun 18, 2021
From: SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 056586/0533 →
Assignment of Assignor's Interest Jun 18, 2021
From: WUXI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 056586/0555 →
Assignment of Assignor's Interest Aug 19, 2021
From: YAO, YIHONG; HUANG, JIAQI; ZHU, SHIGUI; ZHU, WEI
To: CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.; CELLULAR BIOMEDICINE GROUP (WUXI) LTD.
Reel/Frame 057233/0503 →
Assignment of Assignor's Interest Aug 20, 2021
From: CELLULAR BIOMEDICINE GROUP (WUXI) LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 057236/0979 →
Assignment of Assignor's Interest Aug 20, 2021
From: CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 057236/0919 →
Assignment of Assignor's Interest Oct 13, 2021
From: YAO, YIHONG; LI, YANFENG; WEI, YUTIAN; ZHU, SHIGUI
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 057782/0683 →
Assignment of Assignor's Interest Apr 1, 2022
From: ZHU, SHIGUI
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 059474/0308 →
Assignment of Assignor's Interest Apr 19, 2022
From: CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 059637/0335 →
Assignment of Assignor's Interest Apr 19, 2022
From: CELLULAR BIOMEDICINE GROUP (WUXI) LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 059637/0469 →
Assignment of Assignor's Interest Apr 19, 2022
From: YAO, YIHONG; HUANG, JIAQI; ZHU, SHIGUI; ZHU, WEI
To: CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.; CELLULAR BIOMEDICINE GROUP (WUXI) LTD.
Reel/Frame 059637/0001 →
Assignment of Assignor's Interest May 23, 2022
From: YAO, YIHONG; LI, YANFENG; WEI, YUTIAN; ZHU, SHIGUI
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 059981/0669 →
Assignment of Assignor's Interest May 23, 2022
From: YAO, YIHONG; HUANG, JIAQI; ZHU, SHIGUI; ZHU, WEI
To: CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.; CELLULAR BIOMEDICINE GROUP (WUXI) LTD.
Reel/Frame 059983/0711 →
Assignment of Assignor's Interest May 23, 2022
From: CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 059983/0801 →
Assignment of Assignor's Interest May 23, 2022
From: CELLULAR BIOMEDICINE GROUP (WUXI) LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 059983/0987 →
Assignment of Assignor's Interest Jun 3, 2022
From: YAO, YIHONG; HUANG, JIAQI; ZHU, SHIGUI; ZHU, WEI
To: CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.; CELLULAR BIOMEDICINE GROUP (WUXI) LTD.
Reel/Frame 060099/0363 →
Assignment of Assignor's Interest Jun 3, 2022
From: CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 060099/0458 →
Assignment of Assignor's Interest Jun 3, 2022
From: CELLULAR BIOMEDICINE GROUP (WUXI) LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 060099/0542 →
Assignment of Assignor's Interest Jun 14, 2022
From: YAO, YIHONG; LI, YANFENG; WEI, YUTIAN; ZHU, SHIGUI
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 060190/0482 →